An assessment of the effects of central interleukin-1β, -2, -6, and tumor necrosis factor-α administration on some behavioural, neurochemical, endocrine and immune parameters in the rat

Neuroscience

Volumn 84, Issue 3, 1998, Pages 923-933

  Connor, T J ^a   Song, C ^b   Leonard, B E ^a   Merali, Z ^c   Anisman, H ^b  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b CARLETON UNIVERSITY   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Anxiety; Cytokine; HPA axis; Monoamines; Psychoneuroimmunology; Stress

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NEUROENDOCRINOLOGY; NEUROIMMUNOLOGY; NEUROPSYCHOLOGY; NONHUMAN; PRIORITY JOURNAL; PSYCHOPHYSIOLOGY; RAT; STRESS;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; BIOGENIC MONOAMINES; BRAIN CHEMISTRY; CATECHOLAMINES; CORTICOSTERONE; ENDOCRINE GLANDS; IMMUNITY; INJECTIONS, INTRAVENTRICULAR; INTERLEUKIN-1; INTERLEUKIN-2; INTERLEUKIN-6; LYMPHOCYTE ACTIVATION; MALE; RATS; RATS, SPRAGUE-DAWLEY; SPLEEN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 17144449436     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00533-2     Document Type: Article

References (79)

1. Adamec R. E., Sayin U., Brown A. The effects of corticotropin releasing factor (CRH) and handling stress on behavior in the elevated plus-maze test of anxiety. J. Psychopharmac. 5:1991;175-186.
2. Anisman H., Zalcman S., Zacharko R. M. The impact of stressors on immune and central neurotransmitter activity: Bidirectional communication. Rev. Neurosci. 4:1993;147-180.
3. Anisman H., Kokkinidis L., Merali Z. Interleukin-2 decreases accumbal dopamine efflux and responding for rewarding lateral hypothalamic stimulation. Brain Res. 731:1997;1-11.
4. Bauer C., Weingarten S., Senn M., Langhans W. Limited importance of a learned aversion in the hypophagic effect of interleukin-1β Physiol. Behav. 57:1995;1145-1153.
5. Berkenbosch F., Oers J. V., Del Rey A., Tilders F., Besedovsky H. Corticotropin-releasing factor producing neurons in the rat activated by IL-1. Science. 238:1987;524-526.
6. Berkenbosch F., De Goeij D. E. C., Del Rey A., Besedovsky H. O. Neuroendocrine, sympathetic and metabolic responses induced by interleukin-1. Neuroendocrinology. 50:1989;570-576.
7. Blalock J. E. The syntax of immune-neuroendocrine communication. Immunol. Today. 15:1994;504-511.
8. Bluthe R. M., Dantzer R., Kelley K. W. Effects of interleukin-1 receptor antagonist on the behavioral effects of lipopolysaccharide in the rat. Brain Res. 573:1992;318-320.
9. Bremner J. D., Krystal J. H., Southwick S. M., Charney D. S. Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies. Synapse. 23:1996;23-38.
10. Brown R., Zuo L., Vriend C. Y., Nirula R., Janz L., Falk J., Nance D. M., Dyck D. G., Greenberg A. H. Suppression of splenic macrophage interleukin-1 secretion following intracerebroventricular injection of interleukin-1β: Evidence for pituitary adrenal axis and sympathetic control. Cell. Immunol. 131:1991;84-93.
11. Butler L. D., Layman N. K., Riedl P. E., Cain R. L., Shellhaas J., Evans G. F., Zuckerman S. H. Neuroendocrine regulation of in vivo cytokine production and effects: I. In vivo regulatory networks involving the neuroendocrine system, interleukin-1 and tumour necrosis factor-α J. Neuroimmunol. 24:1989;143-153.
12. Caraceni A., Martini C., Belli F., Mascheroni L., Rivoltini L., Arienti F., Cascinelli N. Neuropsychological and neurophysiological assessment of the central effects of interleukin-2 administration. Eur. J. Cancer. 29A:1992;1266-1269.
13. Chiuch C. C., Zukowska-Grojec Z., Kirk K. L., Kopin J. J. 6-fluorocatecholamine as a false adrenergic neurotransmitter. J. Pharmac. exp. Ther. 225:1983;529-533.
14. 1A receptor. In Psychopharmacology: The Fourth Generation of Progress (eds Bloom F. E. and Kupfer D. J.). Raven, New York.
15. Dantzer R. How do cytokines say hello to the brain? Neural versus humoral mediation. Eur. Cytokine Network. 5:1994;271-273.
16. Darling G., Goldstein D. S., Stull R., Gorschboth C. M., Norton J. A. Tumor necrosis factor: Immune endocrine interaction. Surgery. 106:1989;1155-1160.
17. Denicoff K. D., Rubinow D. R., Papa M. Z., Simpson L., Seipp L. A., Lotze M. T., Chang A. E., Rosenstein D., Rosenberg D. A. The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells. Ann. intern. Med. 107:1987;293-300.
18. De Souza E. B., Van Loon G. R. Brain serotonin and catecholamine responses to repeated stress in rats. Brain Res. 367:1986;77-86.
19. Dunn A. J. The role of interleukin-1 and tumor necrosis factor in the neurochemical and neuroendocrine responses to endotoxin. Brain Res. Bull. 29:1992;807-812.
20. Dunn A. J. Endotoxin-induced activation of cerebral catecholamine and serotonin metabolism: Comparison with interleukin-1. J. Pharmac. exp. Ther. 261:1992;964-969.
21. Dunn A. J. The role of cytokines in infection-induced stress. Ann. N.Y. Acad. Sci. 697:1993;189-202.
22. Goujon E., Parnet P., Aubert A., Goodall G., Dantzer R. Corticosterone regulates behavioral effects of lipopolysaccharide and interleukin-1β in mice. Am. J. Physiol. 269:1995;R154-R159.
23. Gresch P. J., Sved A. F., Zigmond M. J., Finlay J. M. Stress-induced sensitization of dopamine and norepinephrine efflux in medial prefrontal cortex of the rat. J. Neurochem. 63:1994;575-583.
24. Hamblin A. S. (1994) Cytokines. In Textbook of Immunopharmacology (eds Dale M. M., Foreman J. C. and Fan T.-P. D.), 3rd edn. Blackwell Scientific Publications, Oxford.
25. Hanisch U., Rowe W., Sharma S., Meaney M. J., Quirion R. Hypothalamic-pituitary-adrenal activity during chronic central administration of interleukin-2. Endocrinology. 135:1994;2465-2474.
26. Hopkins S. J., Rothwell N. J. Cytokines in the nervous system I: Expression and recognition. Trends Neurosci. 18:1995;83-88.
27. Imperato A., Puglisi-Allegra S., Casolini P., Zocchi A., Angelucci L. Stress-induced enhancement of dopamine and acetylcholine release in limbic structures: Role of corticosterone. Eur. J. Pharmac. 165:1989;337-338.
28. Inoue T., Tsuchiya K., Koyama T. Regional changes in dopamine and serotonin activation with various intensity of physical and psychological stress in the rat brain. Pharmac. Biochem. Behav. 49:1994;911-920.
29. Irwin M. Brain corticotropin-releasing hormone and interleukin-1β induced suppression of specific antibody production. Endocrinology. 133:1993;1352-1360.
30. Kabiersch A., Del Rey A., Honegger C. G., Besedovsky H. O. Interleukin-1 induces changes in norepinephrine metabolism in the rat brain. Brain Behav. Immun. 2:1988;267-274.
31. Kalivas P. W., Duffy P. Secective activation of dopamine transmission in the shell of the nucleus accumbens by stress. Brain Res. 675:1995;325-328.
32. Kent S., Bluthe R., Dantzer R., Hardwick A. J., Kelley K. W., Rothwell N. J., Vannice J. L. Different receptor mechanisms mediated the behavioral and pyrogenic effects of interleukin-1. Proc. natn. Acad. Sci. U.S.A. 89:1992;9117-9120.
33. Kent S., Rodriguez F., Kelley K. W., Dantzer R. Reduction in food and water intake induced by microinjection of IL-1 in the ventromedial hypothalamus of the rat. Physiol. Behav. 56:1994;1031-1036.
34. Kobayashi R. M., Palkovits M., Kizer J. S., Jacobowitz D. M. and Kopin I. J. (1976) Selective alterations of catecholamines and tyrosine hydroxylase activity in the hypothalamus following acute and chronic stress. In Catecholamines and Stress (eds Usdin E., Kvetnansky R. and Kopin I. J.). Pergamon, Oxford.
35. Kokkinidis L., Song C., Merali Z., Anisman H. Alterations of rewarding brain stimulation and central monoamines associated with cytokine administration. Soc. Neurosci. Abstr. 22:1996;684.
36. Kluger M. J. Fever: Role of pyrogens and cryogens. Physiol. Rev. 71:1991;93-127.
37. Krueger J. M., Toth L. A., Floyd R., Fang J., Kapas L., Bredow S., Obal F. J. Sleep, microbes and cytokines. Neuroimmunomodulation. 1:1994;100-109.
38. Kvetnansky R., Mitro A., Palkovits M., Brownstein M., Torda T., Vigas M. and Mikulaj L. (1976) Catecholamines in individual hypothalamic nucleui in stressed rats. In Catecholamines and Stress (eds Usdin E., Kvetnansky R. and Kopin I. J.). Pergamon, Oxford.
39. Lacosta S., Merali Z., Anisman H. Cytokine-induced endocrine, neurochemical and behavioral alterations. Soc. Neurosci. Abstr. 21:1995;1397.
40. Lacosta S., Kulczycki J., Merali Z., Anisman H. Behavioral, endocrine and central neurochemical alterations induced by interleukin-1. Soc. Neurosci. Abstr. 22:1996;2058.
41. Lavicky J., Dunn A. J. Endotoxin administration stimulates cerebral catecholamine release in freely moving rats as assessed by microdialysis. J. Neurosci. Res. 40:1995;407-413.
42. Linthorst A. C. E., Flachskamm C., Holsboer F., Reul J. M. H. M. Local administration of recombinant human interleukin-1β in the rat hippocampus increases serotonergic neurotransmission, hypothalamic- pituitary- adrenocortical axis activity, and body temperature. Endocrinology. 135:1994;520-532.
43. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the folin phenol reagent. J. biol. Chem. 193:1951;265-275.
44. Lyson K., McCann S. M. The effect of Interleukin-6 on pituitary hormone release in vivo and in vitro. Neuroendocrinology. 54:1991;262-266.
45. Maier S. F., Watkins L. R. Intracerebroventricular interleukin-1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock. Brain Res. 695:1995;279-282.
46. McIntosh J., Kent P., Merali Z. Microdialysis reveals that both food ingestion and stress enhance CRF release at the central amygdaloid nucleus. Soc. Neurosci. Abstr. 22:1996;1408.
47. Merali Z., Lacosta S., Anisman H. Effects of interleukin-1β and mild stress on alterations of norepinephrine, dopamine and serotonin neurotransmission: A regional microdialysis study. Brain Res. 761:1997;225-235.
48. Mohankumar P. S., Thyagarajan S., Kaleem Quadri S. Interleukin-1 stimulates the release of dopamine and dihydroxyphenylacetic acid from the hypothalamus in vivo. Life Sci. 48:1991;925-930.
49. Naitoh Y., Fukuta J., Tominaga T., Nakaki Y., Tamai S., Mori K., Imura H. Interleukin-6 stimulates the secretion of adrenocorticotropic hormone in conscious, freely moving rats. Biochem. biophys. Res. Commun. 155:1988;1459-1463.
50. Niijima A., Hori T., Aou S., Oomur Y. The effects of interleukin-1β on the activity of adrenal, splenic and renal sympathetic nerves in the rat. J. auton. nerv. Syst. 36:1991;183-190.
51. Nutt D. J. and George D. T. (1989) Serotonin and anxiety. In Handbook of Anxiety (eds Borroughs G., Roth M. and Noyes R.), Vol. 3. Elsevier, Amsterdam.
52. Palazzolo D. L., Quadir S. K. Interleukin-1 inhibits serotonin release from the hypothalamus in vitro. Life Sci. 51:1992;1797-1802.
53. Patchev V. K., Shoaib M., Holsboer F., Almeida O. F. X. The neurosteroid tetrahydroprogesterone counteracts corticotropin-releasing hormone-induced anxiety and alters the release and gene expression of corticotropin-releasing hormone in the rat hypothalamus. Neuroscience. 62:1994;265-271.
54. Pauli S., Linthorst A. C. E., Reul J. M. H. M. Tumor necrosis factor-α, interleukin-1β and interleukin-2 produce differential effects on hippocampal serotonergic neurotransmission, free corticosterone levels, body temperature and behavior. Soc. Neurosci. Abstr. 22:1996;1351.
55. Paxinos G. and Watson C. (1982) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
56. Pellow S., Chopin P., File S., Briley M. Validation of open: closed arm entries in an elevated plus maze as a measure of anxiety in the rat. J. Neurosci. Meth. 14:1985;149-167.
57. Plata-Salaman C. R. Immunomodulators and feeding regulation: A humoral link between the immune and nervous systems. Brain Behav. Immun. 3:1989;193-213.
58. Popov N., Pohle W., Rosler V., Matthies H. Regionale verteilung von gamma-aminobuttersaure, glutaminsaure, asparaginsaure, dopamin, noradreanlin and serotonin in rattenhirn. Acta med. biol. germany. 18:1967;695-702.
59. Rettori V., Mikenkovic L., Beutler B. A., McCann S. M. Hypothalamic action of cachectin to alter pituitary hormone release. Brain Res. Bull. 23:1989;471-475.
60. Rivier C., Vale W., Brown M. In the rat, interleukin-1α and β stimulate adrenocorticotropin and catecholamine release. Endocrinology. 125:1989;3096-3102.
61. Robinson T. E., Becker J. B., Young E. A., Akil H., Castaneda E. The effects of footshock stress on regional brain dopamine metabolism and pituitary β-endorphin release in rats previously sensitized to amphetamine. Neuropharmacology. 26:1987;679-691.
62. Rothwell N. J., Hopkins S. J. Cytokines and the nervous system II: actions and mechanisms of action. Trends Neurosci. 18:1995;130-136.
63. Sakic B., Szechtman H., Denburg J. A. Interleukin-6-induced "anhedonia" Psychoneuroimmunol. Res. Soc. Abstr. A:1996;25.
64. Schobitz B., De Kloet E. R., Sutanto W., Holsboer F. Cellular localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain. Eur. J. Neurosci. 5:1993;1426-1435.
65. Schobitz B., De Kloet E. R., Holsboer F. Gene expression and function of interleukin 1, interleukin 6 and tumour necrosis factor in the brain. Prog. Neurobiol. 44:1994;397-432.
66. Schobitz B., Holsboer F., De Kloet E. R. Cytokines in the healthy and diseased brain. News Physiol. Sci. 9:1994;138-142.
67. Seegal R. F., Brosch K. O., Bush G. High-performance liquid chromatography of biogenic amines and metabolites in brain, cerebrospinal fluid, urine and plasma. J. Chromat. 377:1986;131-144.
68. Sharp B. M., Matta S. G., Peterson P. K., Newton R., Chao C., McAllen K. Tumour necrosis factor-α is a potent ACTH secretagogue: Comparison to IL-1β Endocrinology. 124:1989;3131-3133.
69. Shintani F., Nakaki T., Kanba S., Sato K., Yagi G., Shiozawa M., Asio S., Kato R., Asai M. Involvement of interleukin-1 in immobilization stress-induced increase in adrenocorticotropic hormone and in the release of hypothalamic monoamines in the rat. J. Neurosci. 15:1995;1961-1970.
70. Shintani F., Kanba S., Nakaki T., Nibuya M., Kinoshita N., Suzuki E., Yagi G., Kato R., Asai M. Interleukin-1β augments release of norepinephrine, dopamine and serotonin in the rat hypothalamus. J. Neurosci. 13:1993;3574-3581.
71. Song C., Merali Z., Lacosta S., Anisman H. Effects of cytokines and stress on the neurotransmitter release in the nucleus accumbens: An in vivo microdialysis study. Psychoneuroimmunol. Res. Soc. Abstr. O:1996;24.
72. Spadaro F., Dunn A. J. Intracerebroventricular administration of interleukin-1 to mice alters investigation of stimuli in a new environment. Brain Behav. Immun. 4:1990;308-322.
73. Sundar S. K., Becker K. J., Cieprial M. A., Carpenter M. D., Rankin L. A., Fleener S. L., Ritchie J. C., Simson P. E., Weiss J. M. Intracerebroventricular infusion of interleukin 1 rapidly decreases peripheral cellular immune responses. Proc. natn. Acad. Sci. U.S.A. 86:1989;6398-6402.
74. Sundar S. K., Cieprial M. A., Kilts C., Ritchie J. C., Weiss J. M. Brain IL-1-induced immunosuppression occurs through activation of both pituitary-adrenal axis and sympathetic nervous system by corticotropin-releasing factor. J. Neurosci. 10:1990;3701-3706.
75. Tazi A., Dantzer R., Crestani F., Le Moal M. Interleukin-1 induces conditioned taste aversion in rats: a possible explanation for its pituitary-adrenal stimulating activity. Brain Res. 473:1988;369-371.
76. Wang J., Dunn A. J. Mouse interleukin-6 increases brain tryptophan and serotonin metabolism and stimulated the HPA axis. Psychoneuroimmunol. Res. Soc. Abstr. O:1996;26.
77. Yirmiya R., Avitsur R., Donchin O., Cohen E. Interleukin-1 inhibits sexual behavior in female but not male rats. Brain Behav. Immun. 9:1995;220-233.
78. Yirmiya R. Endotoxin produces a depressive-like episode in rats. Brain Res. 711:1996;163-174.
79. Zalcman S., Green-Johnson J. M., Murray L., Nance D. M., Dyck D., Anisman H., Greenberg A. H. Cytokine-specific central monoamine alterations induced by Interleukin-1, -2 and -6. Brain Res. 643:1994;40-49.